|
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
CHEBI:146263 |
|
N- (3- {[alpha- D- GalN- (1- >4)- alpha- D- GalN- (1- >4)- alpha- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
A trisaccharide derivative in which α-D-galactosaminyl-(1→4)-α-D-galactosaminyl-(1→4)-α-D-galactosamine is linked glycosidically to biotin via a (21-oxo-3,6,9,12,15,18-hexaoxa-22-azapentacosan-1-yl)amino spacer. One of a set of synthesised biotinylated oligo-α-(1→4)-D-galactosamines comprising from two to six monosaccharide units, along with their N-acetylated derivatives (PMID:31913631), aimed at analysing the specificity of the antibody responses to a complex exopolysaccharide galactosaminogalactan found in Aspergillus fumigatus, the most important airborne human fungal pathogen in industrialized countries. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C46H85N7O22S/c47- 33- 38(60) 37(59) 27(22- 54) 71- 44(33) 74- 42- 29(24- 56) 73- 45(35(49) 40(42) 62) 75- 41- 28(23- 55) 72- 43(34(48) 39(41) 61) 70- 9- 3- 7- 50- 32(58) 6- 10- 64- 12- 14- 66- 16- 18- 68- 20- 21- 69- 19- 17- 67- 15- 13- 65- 11- 8- 51- 31(57) 5- 2- 1- 4- 30- 36- 26(25- 76- 30) 52- 46(63) 53- 36/h26- 30,33- 45,54- 56,59- 62H,1- 25,47- 49H2,(H,50,58) (H,51,57) (H2,52,53,63) /t26- ,27+,28+,29+,30- ,33+,34+,35+,36- ,37- ,38+,39+,40+,41- ,42- ,43- ,44+,45+/m0/s1 |
JSVPUGSZZUAPSX-UJIDSKHPSA-N |
[C@H] 1([C@@H] ([C@H] ([C@H] ([C@H] (O1) CO) O[C@@H] 2[C@@H] ([C@H] ([C@H] ([C@H] (O2) CO) O) O) N) O) N) O[C@@H] 3[C@@H] ([C@H] ([C@H] (O[C@@H] 3CO) OCCCNC(CCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H] 4[C@] 5(NC(N[C@] 5(CS4) [H] ) =O) [H] ) =O) =O) N) O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
View more via ChEBI Ontology
Outgoing
|
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146263)
is a
biotins
(CHEBI:51570)
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146263)
is a
trisaccharide derivative
(CHEBI:63571)
|
|
N- (3- {[2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranosyl]oxy}propyl)- 23- oxo- 27- [(3aS,4S,6aR)- 2- oxohexahydro- 1H- thieno[3,4- d]imidazol- 4- yl]- 4,7,10,13,16,19- hexaoxa- 22- azaheptacosan- 1- amide
|
(3aS,4S,6aR)- N- [25- [[O- 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- O- 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranosyl]oxy]- 21- oxo- 3,6,9,12,15,18- hexaoxa- 22- azapentacos- 1- yl]hexahydro- 2- oxo- 1H- thieno[3,4- d]imidazole- 4- pentanamide
|
ChEBI
|
3- (21- biotinamino- 4,7,10,13,16,19- hexaoxagenicaminoamino)- propyl 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranoside
|
ChEBI
|
N- (3- {[α- D- galactosaminyl- (1→4)- α- D- galactosaminyl- (1→4)- α- D- galactosaminyl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxaheptacosan- 1- amide
|
ChEBI
|
31913631
|
PubMed citation
|
Europe PMC
|
|